Latest news on Boston Scientific (BSX)
Results, leadership changes, dividends, financing and deals at Boston Scientific, each with its sources linked.
-
Boston Scientific discloses $7.25bn sale of notes
A $7.25bn sale of notes by Boston Scientific (BSX) was disclosed in a regulatory filing on 20 November.
-
Boston Scientific names David Wichmann as lead independent director
David S. Wichmann has been appointed lead independent director of Boston Scientific (NYSE: BSX), effective 1 January 2027, the company said on 17 November.
These stories are written automatically by Stockertim from company filings, press releases and exchange disclosures, and each one links its sources. How Stockertim Newswire works. They are information, not financial advice.